How to Get Rapamycin (Sirolimus) in New Hampshire

Rapamycin Prescribing Is Legal Via Telehealth in New Hampshire

New Hampshire permits licensed providers to prescribe rapamycin through telehealth consultations, with no requirement for an initial in-person visit for non-controlled substances. Sirolimus is not a controlled substance under either federal or New Hampshire law, so a video or audio visit with a properly credentialed prescriber satisfies the state's standard of care for establishing a provider-patient relationship.

The FDA-approved prescribing information for sirolimus covers prevention of renal transplant rejection in adults. Off-label use for geroprotection falls under the physician's clinical discretion. New Hampshire does not restrict off-label prescribing by statute, provided the prescriber documents an appropriate medical rationale.

Telehealth platforms serving NH patients typically operate under multistate medical licenses or hold active New Hampshire Board of Medicine credentials. Before booking a consultation, verify that your provider holds an active license through the New Hampshire Office of Professional Licensure and Certification.

Who Can Prescribe Sirolimus in New Hampshire

Three categories of providers hold prescriptive authority in the state. MDs and DOs have unrestricted prescriptive authority. Nurse practitioners (APRNs) with full practice authority can prescribe independently under New Hampshire RSA 326-B. Physician assistants prescribe under a collaborative agreement with a supervising physician.

Any of these providers can write a sirolimus prescription, including for off-label longevity use. The prescriber must document the clinical indication, relevant lab results, and the risk-benefit discussion in the patient record.

For off-label longevity protocols, some patients prefer working with physicians board-certified in internal medicine, endocrinology, or anti-aging medicine. The American Academy of Anti-Aging Medicine (A4M) maintains a provider directory, though board certification in longevity medicine is not a requirement to prescribe rapamycin. The PEARL trial (N=40, published in Aging Cell, 2024) provided early evidence that low-dose rapamycin (5 mg/week for 8 weeks) did not produce serious adverse events in healthy middle-aged adults, supporting the safety profile of weekly dosing protocols now used by many off-label prescribers [1].

Required Labs Before Starting Rapamycin in New Hampshire

Baseline bloodwork is non-negotiable before a responsible prescriber will write a sirolimus script. The standard pre-prescribing panel includes a complete blood count (CBC), comprehensive metabolic panel (CMP), fasting lipid panel, and fasting glucose or hemoglobin A1c.

Sirolimus can raise triglycerides and LDL cholesterol. In the original transplant registration trial, hyperlipidemia occurred in 38 to 57% of patients on daily dosing [2]. Weekly off-label protocols use substantially lower cumulative doses, but lipid monitoring remains necessary. The Endocrine Society's clinical practice guidelines recommend fasting lipid assessment whenever initiating medications known to alter lipid metabolism.

A baseline complete blood count matters because rapamycin can cause mild thrombocytopenia and leukopenia at higher doses. Most off-label prescribers recheck CBC and lipids at 4 to 6 weeks, then every 3 to 6 months during ongoing therapy.

Labwork is widely available at Quest Diagnostics and Labcorp locations across New Hampshire, including sites in Manchester, Nashua, Concord, and Portsmouth. Some telehealth providers partner with mobile phlebotomy services that draw blood at the patient's home.

The 503A Compounding Pharmacy Route in New Hampshire

New Hampshire licenses 503A compounding pharmacies that can prepare patient-specific sirolimus formulations. Under section 503A of the Federal Food, Drug, and Cosmetic Act, a compounding pharmacy may prepare a drug pursuant to a valid prescription for an individual patient. This is distinct from 503B outsourcing facilities, which can produce larger batches without patient-specific prescriptions.

Compounded sirolimus may come as a capsule or oral solution in customized doses (commonly 1 mg, 2 mg, 3 mg, 5 mg, or 6 mg capsules for weekly protocols). Some patients prefer compounded formulations because they allow precise dose titration that commercial tablets do not support. Generic sirolimus tablets are available in 0.5 mg, 1 mg, and 2 mg strengths, so a patient on a 5 mg weekly dose would need to combine multiple tablets unless using a compounded capsule.

The New Hampshire Board of Pharmacy oversees compounding pharmacy licensure. A 503A pharmacy located in another state may ship compounded sirolimus to a New Hampshire address if that pharmacy holds a nonresident pharmacy license issued by the New Hampshire Board.

Compounded sirolimus typically costs $40 to $120 per month depending on dose and pharmacy, comparable to or slightly above generic tablet pricing. Turnaround time from prescription receipt to delivery averages 3 to 7 business days for established compounding pharmacies.

Generic Sirolimus vs. Brand Rapamune: Cost and Access

Pfizer's brand product Rapamune carries a list price exceeding $900 per month for daily transplant dosing. Generic sirolimus tablets, manufactured by companies including Greenstone, Biocon, and Dr. Reddy's, cost dramatically less.

For a weekly off-label protocol using 5 to 6 mg per week, generic tablet costs typically range from $30 to $90 per month at retail pharmacies without insurance. GoodRx and similar discount platforms frequently list sirolimus 1 mg tablets (quantity 30) at $25 to $60 at New Hampshire pharmacies including CVS, Walgreens, and Rite Aid locations.

New Hampshire Medicaid does not cover sirolimus for off-label longevity indications. Commercial insurance plans may cover sirolimus for transplant rejection prevention but will typically deny coverage for anti-aging use. Prior authorization is almost always required regardless of indication.

Patients paying out of pocket should compare prices across at least three pharmacies. The same generic sirolimus can vary by 300% in price between pharmacies in the same city. Mail-order pharmacies and 503A compounders sometimes offer the lowest per-unit cost for patients on stable long-term protocols.

Prior Authorization Requirements in New Hampshire

When insurance is involved, prior authorization (PA) for sirolimus requires specific clinical documentation. The typical PA submission includes the patient's diagnosis (ICD-10 code), the prescriber's clinical rationale, relevant lab results, documentation that the patient has tried or cannot use alternative therapies, and a letter of medical necessity.

For transplant patients, PA approval is generally straightforward with documentation of the transplant date, current immunosuppressive regimen, and most recent trough levels. For off-label longevity use, PA denial is the norm. Most commercial plans in New Hampshire classify longevity or geroprotective use as investigational.

New Hampshire follows a two-step appeal process for PA denials. The first appeal goes to the insurer's internal review board. If denied again, patients can request an external independent review through the New Hampshire Insurance Department. The external review decision is binding on the insurer under RSA 420-J:5-b.

In practice, most off-label rapamycin users in New Hampshire bypass the PA process entirely and pay cash. A 2023 survey by the Alliance for Longevity Initiatives found that over 80% of off-label rapamycin patients in the United States pay out of pocket [3].

How Long Until You Receive Rapamycin in New Hampshire

The timeline from initial consultation to medication in hand depends on the prescribing pathway. The fastest route runs about 3 to 5 days total. A telehealth consultation can happen within 24 to 48 hours of scheduling. If the provider has lab results in hand (from a recent panel), the prescription can be sent electronically the same day as the visit.

Retail pharmacies with generic sirolimus in stock can fill the prescription within hours. Not all pharmacies stock sirolimus routinely, so calling ahead saves time. Compounding pharmacies add 3 to 7 business days for preparation and shipping.

If you need new baseline labs, add 2 to 5 days for the blood draw, processing, and result delivery. Some labs offer next-day results for standard panels.

A realistic end-to-end timeline for a new patient without recent labs: 7 to 14 days from first scheduling a telehealth appointment to receiving sirolimus at home or picking it up at a pharmacy.

Safety Monitoring and Ongoing Management

Rapamycin requires ongoing clinical oversight. This is not a "set and forget" medication. After the initial 4 to 6 week labs, most prescribers settle into a monitoring cadence of every 3 to 6 months.

Key monitoring parameters include fasting lipids (triglycerides rise in roughly 40% of patients on daily dosing, less frequently on weekly protocols), CBC (watch for neutropenia below 1,500 cells/mcL), fasting glucose (rapamycin can impair glucose tolerance acutely, though the PEARL trial showed no significant glucose changes at 5 mg/week over 8 weeks [1]), and renal function via serum creatinine and eGFR.

Mouth sores (aphthous ulcers) are the most commonly reported side effect in off-label users, occurring in roughly 20 to 30% of patients at some point during therapy [4]. These are usually mild, dose-dependent, and resolve with dose reduction or brief pauses.

The National Institute on Aging's Interventions Testing Program demonstrated that rapamycin extended median lifespan by 9 to 14% in genetically heterogeneous mice across three independent test sites [5]. Human longevity data remains preliminary, and patients should understand that current off-label use is based on extrapolation from preclinical evidence and early-phase human trials.

New Hampshire Pharmacy Regulations Affecting Sirolimus Access

New Hampshire's Board of Pharmacy enforces specific rules that affect sirolimus dispensing. The state requires electronic prescribing (e-prescribing) for most medications, though sirolimus is exempt from the controlled-substance-specific e-prescribing mandates since it is not a scheduled drug. Prescribers can transmit sirolimus prescriptions electronically, by fax, or by phone.

Nonresident pharmacies (including 503A compounders in other states) must hold a New Hampshire nonresident pharmacy license to ship medications to NH addresses. The Board publishes a searchable license verification tool where patients can confirm a pharmacy's active license status.

New Hampshire allows prescription transfers between pharmacies under standard rules. A patient who started sirolimus while living in another state can transfer the remaining refills to a New Hampshire pharmacy. The receiving pharmacy contacts the originating pharmacy directly to complete the transfer.

Patients should store sirolimus tablets at controlled room temperature (20 to 25°C / 68 to 77°F) and protect them from light. Compounded capsules may have specific storage requirements listed on the pharmacy label.